科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/10/04 | 3,430 | 3,488 | 3,409 | 3,473 | +15 | +0.4% | 211,200 |
| 2023/10/03 | 3,470 | 3,480 | 3,432 | 3,458 | -12 | -0.3% | 208,600 |
| 2023/10/02 | 3,516 | 3,524 | 3,470 | 3,470 | -30 | -0.9% | 248,600 |
| 2023/09/29 | 3,515 | 3,524 | 3,492 | 3,500 | -23 | -0.7% | 234,900 |
| 2023/09/28 | 3,500 | 3,551 | 3,491 | 3,523 | -109 | -3% | 197,500 |
| 2023/09/27 | 3,591 | 3,633 | 3,570 | 3,632 | +30 | +0.8% | 271,400 |
| 2023/09/26 | 3,598 | 3,622 | 3,575 | 3,602 | +4 | +0.1% | 198,600 |
| 2023/09/25 | 3,575 | 3,610 | 3,570 | 3,598 | +30 | +0.8% | 163,500 |
| 2023/09/22 | 3,575 | 3,585 | 3,561 | 3,568 | -21 | -0.6% | 186,500 |
| 2023/09/21 | 3,617 | 3,625 | 3,582 | 3,589 | -17 | -0.5% | 159,100 |
| 2023/09/20 | 3,614 | 3,628 | 3,600 | 3,606 | -10 | -0.3% | 189,600 |
| 2023/09/19 | 3,647 | 3,654 | 3,602 | 3,616 | -21 | -0.6% | 202,600 |
| 2023/09/15 | 3,569 | 3,648 | 3,569 | 3,637 | -2 | -0.1% | 699,500 |
| 2023/09/14 | 3,600 | 3,640 | 3,573 | 3,639 | +47 | +1.3% | 236,200 |
| 2023/09/13 | 3,602 | 3,608 | 3,557 | 3,592 | -4 | -0.1% | 196,300 |
| 2023/09/12 | 3,561 | 3,614 | 3,557 | 3,596 | +45 | +1.3% | 170,400 |
| 2023/09/11 | 3,560 | 3,574 | 3,542 | 3,551 | -18 | -0.5% | 150,600 |
| 2023/09/08 | 3,551 | 3,579 | 3,543 | 3,569 | +18 | +0.5% | 156,600 |
| 2023/09/07 | 3,560 | 3,565 | 3,541 | 3,551 | -11 | -0.3% | 168,300 |
| 2023/09/06 | 3,565 | 3,565 | 3,533 | 3,562 | +2 | +0.1% | 180,900 |
| 2023/09/05 | 3,577 | 3,577 | 3,546 | 3,560 | -17 | -0.5% | 148,400 |
| 2023/09/04 | 3,575 | 3,585 | 3,551 | 3,577 | +4 | +0.1% | 109,600 |
| 2023/09/01 | 3,560 | 3,586 | 3,535 | 3,573 | -7 | -0.2% | 162,300 |
| 2023/08/31 | 3,573 | 3,602 | 3,544 | 3,580 | +4 | +0.1% | 162,200 |
| 2023/08/30 | 3,548 | 3,591 | 3,543 | 3,576 | +23 | +0.6% | 427,300 |
| 2023/08/29 | 3,550 | 3,553 | 3,515 | 3,553 | -1 | ±0% | 256,700 |
| 2023/08/28 | 3,568 | 3,578 | 3,554 | 3,554 | -2 | -0.1% | 81,900 |
| 2023/08/25 | 3,556 | 3,574 | 3,550 | 3,556 | +8 | +0.2% | 86,700 |
| 2023/08/24 | 3,520 | 3,555 | 3,512 | 3,548 | ±0 | ±0% | 81,700 |
| 2023/08/23 | 3,535 | 3,554 | 3,530 | 3,548 | -9 | -0.3% | 72,800 |
| 2023/08/22 | 3,544 | 3,565 | 3,523 | 3,557 | +13 | +0.4% | 80,800 |
| 2023/08/21 | 3,555 | 3,580 | 3,523 | 3,544 | -3 | -0.1% | 153,500 |
| 2023/08/18 | 3,506 | 3,566 | 3,504 | 3,547 | +25 | +0.7% | 144,700 |
| 2023/08/17 | 3,575 | 3,575 | 3,510 | 3,522 | -47 | -1.3% | 188,600 |
| 2023/08/16 | 3,556 | 3,582 | 3,541 | 3,569 | -12 | -0.3% | 105,700 |
| 2023/08/15 | 3,599 | 3,615 | 3,573 | 3,581 | -18 | -0.5% | 85,800 |
| 2023/08/14 | 3,601 | 3,633 | 3,582 | 3,599 | -6 | -0.2% | 142,000 |
| 2023/08/10 | 3,593 | 3,605 | 3,566 | 3,605 | +16 | +0.4% | 115,400 |
| 2023/08/09 | 3,551 | 3,590 | 3,531 | 3,589 | +44 | +1.2% | 132,500 |
| 2023/08/08 | 3,538 | 3,560 | 3,528 | 3,545 | +24 | +0.7% | 178,400 |
| 2023/08/07 | 3,548 | 3,569 | 3,496 | 3,521 | -21 | -0.6% | 191,700 |
| 2023/08/04 | 3,526 | 3,545 | 3,501 | 3,542 | +16 | +0.5% | 164,300 |
| 2023/08/03 | 3,519 | 3,552 | 3,502 | 3,526 | -9 | -0.3% | 199,800 |
| 2023/08/02 | 3,531 | 3,562 | 3,526 | 3,535 | -30 | -0.8% | 131,300 |
| 2023/08/01 | 3,538 | 3,567 | 3,529 | 3,565 | +24 | +0.7% | 168,500 |
| 2023/07/31 | 3,539 | 3,543 | 3,509 | 3,541 | +43 | +1.2% | 288,200 |
| 2023/07/28 | 3,465 | 3,505 | 3,454 | 3,498 | +3 | +0.1% | 186,800 |
| 2023/07/27 | 3,483 | 3,495 | 3,474 | 3,495 | +2 | +0.1% | 169,600 |
| 2023/07/26 | 3,492 | 3,499 | 3,479 | 3,493 | -9 | -0.3% | 141,400 |
| 2023/07/25 | 3,515 | 3,516 | 3,491 | 3,502 | -20 | -0.6% | 103,600 |
151～
200
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 344,000円 | +4.2% | -21.6% | 4.36% | 23.26倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 369,300円 | +1.2% | -6.3% | 3.36% | 10.15倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 191,500円 | +56.7% | +357.2% | 0.00% | 17.73倍 | 6.15倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 316,000円 | +9.8% | -12.1% | 2.85% | 12.36倍 | 0.63倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 273,000円 | +14.7% | -28.1% | 2.20% | 11.58倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
